Penn Heart and Vascular

Ventricular Tachycardia Procedures at the Cardiac Arrhythmia Program

Quality & Outcomes: Ventricular Tachycardia Procedures

In 2012, the HUP EP team performed 277 ablations for ventricular tachycardia including 42 epicardial ablation procedures, and received patient referrals from across the United States for the treatment of VT.

VT Ablation Case Volumes at HUP FY 2004 - FY 2012, N = 2332

Year Endocardial Epicardial
2004 85 6
2005 113 8
2006 110 18
2007 142 32
2008 170 36
2009 222 41
2010 243 43
2011 280 47
2012 277 42
  • Endocardial
  • Epicardial

Surgical Treatment of Ventricular Tachycardia

Penn electrophysiologists and surgeons are defining new roles for surgery in the treatment of cardiovascular arrhythmias. Detailed mapping allows the precise placement of cryoablation lesions in the OR in patients with VT and nonischemic cardiomyopathy.
Nonsurgical Approaches to VT

Identifying Epicardial Ventricular Tachycardia in Nonischemic Cardiomyopathy

HUP's EP team uses a percutaneous nonsurgical approach that targets the epicardium to eliminate VT associated with nonischemic cardiomyopathy of the right and left ventricles in patients experiencing multiple shocks from their ICDs for recurrences of VT. Without VT control, heart transplantation is frequently the only option remaining for these patients.

Preventing Sudden Death and Advancing Treatment of Ventricular Tachycardia

Penn is a national leader in VT ablation procedures. Electrophysiologists from the Hospital of the University of Pennsylvania pioneered substrate-based catheter ablation to treat unmappable ventricular tachycardias, as well as the use of intracardiac echo to facilitate mapping and ablation of a variety of rhythm disorders.

Penn Heart & Vascular Clinical Activity Reports

See Interactive Report or Download PDF Version